Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
40.92
-1.49 (-3.51%)
May 13, 2025, 4:00 PM - Market closed
Merus Market Cap
Merus has a market cap or net worth of $2.83 billion as of May 14, 2025. Its market cap has increased by 8.86% in one year.
Market Cap
2.83B
Enterprise Value
2.20B
1-Year Change
8.86%
Ranking
Category
Stock Price
$40.92
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $2.83B, an increase of 1,879.71%. That is a compound annual growth rate of 39.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 2.94B | 1.96% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |